Spring Clock Change Linked to Higher Risk of Retinal Vascular Disease

Northwestern Medicine researchers have identified a link between semiannual clock changes and the incidence of retinal vascular disease. According to a study published in Scientific Reports, the risk of developing these sight-threatening conditions increases by up to 30% in the month following the spring transition to daylight saving time, while the fall return to standard … Read more

Study identifies genetic cause linked to juvenile glaucoma risk

The Shift Toward Genetic Screening in Glaucoma For decades, glaucoma has been viewed primarily as a condition of the elderly. However, a paradigm shift is occurring in ophthalmology as researchers uncover the genetic drivers behind early-onset forms of the disease. The discovery of the FOXC1 duplication as a contributor to juvenile open-angle glaucoma (JOAG) is … Read more

Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in US

Sildenafil and Eye Health: Emerging Trends and What Men Need to Grasp Phosphodiesterase type 5 inhibitors (PDE5i), commonly used to treat erectile dysfunction, are increasingly under scrutiny for potential links to ocular adverse events. While case reports and smaller studies have hinted at associations with conditions like serous retinal detachment (SRD), retinal vascular occlusion (RVO), … Read more

Addiction consults improve care for drug-related eye infections

The Intertwined Future of Ophthalmology and Addiction Care A recent study published in Ophthalmology Retina, led by Eric Gaier, MD, PhD, and Dean Eliott, MD, of Mass Eye and Ear, highlights a critical intersection: the link between injection drug utilize, eye infections, and access to addiction treatment. The research underscores a growing trend – recognizing … Read more

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel

The Growing Influence of Pharma Funding in Ophthalmology: What Does the Future Hold? A recent disclosure of financial ties within the ophthalmology field – specifically, a list of researchers receiving grants and honoraria from major pharmaceutical companies like AbbVie, Bayer, and Roche – highlights a trend that’s been quietly accelerating for years. While not inherently … Read more

Why Stress, Sleep Loss & Over‑Skincare Age Your Skin Faster – 4‑Step Dermatologist Tips

How Stress, Sleep, and Over‑loaded Skincare Are Shaping the Future of Anti‑Aging Modern life has turned stress into a daily companion, and that partnership is rewriting the rules of skin health. Researchers now link chronic cortisol spikes to faster collagen breakdown, while sleep scientists show that each night of poor rest can shave years off … Read more

HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure

Heart Failure: A Paradigm Shift Towards Prevention and Proactive Care The landscape of heart failure management is undergoing a significant transformation. A recent joint statement by the Heart Failure Society of America (HFSA) and the American Society for Preventive Cardiology (ASPC) underscores a critical shift: moving away from solely treating heart failure to proactively preventing … Read more

6 Endocrinology Headlines You May Have Missed in July 2025

Endocrinology’s Forward March: Key Trends Reshaping Diabetes, CKD, and Growth Hormone Deficiency The field of endocrinology is experiencing a period of unprecedented advancement. From groundbreaking clinical trial results to innovative therapies, the pace of progress in managing conditions like diabetes, chronic kidney disease (CKD), and growth hormone deficiency is accelerating. This article delves into the … Read more

Remibrutinib for CSU Treatment

The Future of CSU Treatment: A Look at Oral Therapies and Patient Empowerment Chronic Spontaneous Urticaria (CSU), also known as chronic hives, can significantly impact a patient’s quality of life. Finding effective and convenient treatments is paramount. Recent advancements, particularly in oral therapies like remibrutinib, are reshaping the landscape, offering new hope and opportunities for … Read more

Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes

Semaglutide and PAD: Unveiling a Vascular Protective Revolution The medical world is abuzz with the latest findings on semaglutide, particularly its potential to revolutionize the treatment of peripheral artery disease (PAD) in individuals with type 2 diabetes. Recent data from the STRIDE trial, presented at the American Diabetes Association (ADA) Scientific Sessions, suggests the benefits … Read more